Results 51 to 60 of about 23,433 (212)

Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp. [PDF]

, 2017
Background: candidiasis is the primary fungal infection encountered in patients undergoing prolonged hospitalization, and the fourth leading cause of nosocomial bloodstream infections. One of the most important Candida spp.
Henriques, Mariana, Rodrigues, Célia F.
core   +2 more sources

Disseminated Histoplasmosis: An Unusual Finding at ROSE

Diagnostic Cytopathology, Volume 54, Issue 6, Page E146-E148, June 2026.
ABSTRACT We describe an unusual case in which disseminated histoplasmosis was suspected at the time of of rapid on‐site assessment (ROSE) performed during endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA). The patient was a renal transplant recipient with fever, mild anemia, bilateral lung infiltrates and mediastinal ...
Erika E. Doxtader, Jona Banzon, Sanjay Mukhopadhyay   +2 more
wiley   +1 more source

Diagnosis and Treatment of Foot Fusarium Infection Confirmed by Molecular Identification: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Fusarium spp. are opportunistic fungal pathogens, with an increasing incidence of infection observed in immunocompromised populations. Due to the non‐specific clinical manifestations of cutaneous Fusarium infections, they are often misdiagnosed or overlooked.
Yulin Wang, Danyue He, Jie Hu, Qi Zhao, Ruyi Wang, Yiyang Hu, Jia Cai, Xiangning Li, Lili Tang, Xing Fan   +9 more
wiley   +1 more source

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children [PDF]

, 2016
BACKGROUND Liposomal amphotericin B (LAmB) is widely used in the treatment of invasive fungal disease (IFD) in adults and children. There are relatively limited PK data to inform optimal dosing in children that achieves systemic drug exposures ...
Aljayyoussi, Ghaith, Gonzalez, Corina, Groll, Andreas H, Hope, William W, Jarosinski, Paul F, Lestner, Jodi M, Seibel, Nita L, Shad, Aziza, Walsh, Thomas J, Wood, Lauren V   +9 more
core   +4 more sources

Brain Involvement in Leishmaniasis

Cell Biochemistry and Function, Volume 44, Issue 4, April 2026.
ABSTRACT Leishmaniasis is a neglected tropical disease caused by infection with the protozoan parasite Leishmania and it is a significant global health problem. The disease has a wide clinical spectrum, from tegumentary leishmaniasis (TL) that encompasses cutaneous (CL), mucosal (ML) and cutaneous‐diffuse (CDL) forms, to the potentially fatal systemic ...
Camila S. Freitas, Eduardo A. F. Coelho, Myron Christodoulides   +2 more
wiley   +1 more source

Acute Invasive Pulmonary Aspergillosis With CNS Dissemination in an Immunocompetent Individual: A Case Report

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Invasive pulmonary aspergillosis can occur in patients without classical immunosuppression, particularly those with COPD and corticosteroid exposure. Early recognition, prompt antifungal therapy, and vigilance for neurological symptoms are essential to prevent central nervous system dissemination, which carries high mortality and significant ...
Barbare Khatiashvili, Sarah Saife, Islam Rajab, Malina Mohtadi, Arham Hazari, Ghassan Makhoul, Aqsa Zoey Sorathia, Ahmad Huzien, Shivanck Upadhyay   +8 more
wiley   +1 more source

Clinical and laboratory evaluation of patients with visceral leishmaniasis undergoing different therapeutic regimens of liposomal amphotericin B

Acta Scientiarum. Health Sciences
Visceral Leishmaniasis (VL) is an infectious disease caused by protozoa of the Leishmania genus and is transmitted to humans by the bite of infected female Lutzomyia sandflies.
Fernanda Santana da Silva, Elder Andrade Oliveira Filho , Maria Luísa Santos Fernandes, Gabriel Donner Oliveira, Victor Hugo Dantas Guimarães   +4 more
doaj   +1 more source

Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis. [PDF]

, 2017
Visceral leishmaniasis is a neglected tropical disease that causes significant morbidity and mortality worldwide. Characterization of the pharmacokinetics and pharmacodynamics of antileishmanial drugs in preclinical models is important for drug ...
Croft, Simon L, Harris, Andy, Qaiser, Zeeshan, Seifert, Karin, Voak, Andrew A   +4 more
core   +2 more sources

Paresthesia and Facial Bone Destruction due to Chronic Granulomatous Invasive Aspergillosis in the Left Maxillary Sinus

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT We report a case of chronic granulomatous invasive aspergillosis in a 56‐year‐old male teacher from South Kordofan, Sudan, who underwent surgery in 2007 to remove his left orbital aspergillus granuloma. The patient developed progressive facial swelling beginning in 2017 and paraesthesia in the left zygomatico‐maxillary region, despite initial ...
Rawa Badri, Matthew C. Fisher, Ahmed Hassan Fahal   +2 more
wiley   +1 more source

Visceral Leishmaniasis in Somalia: Diagnosis and Management of a Classic Case in a Resource‐Limited Endemic Setting

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Visceral Leishmaniasis (VL), a severe systemic neglected tropical disease (NTD) caused by Leishmania donovani complex protozoa, poses a significant public health threat, particularly in East Africa, where it is fatal if untreated. Somalia is known to be endemic, but the true burden and programmatic challenges are poorly documented due to long ...
Abdirahman Nuur Hussein, Abdirahman Omer Ali, Ridwan Zakariye Ahmed, Sihaam Mohamed Abdirahman, Ahmed Dek Abdiwahab   +4 more
wiley   +1 more source